DALLAS, TX and MIAMI, FL-- Med-Rite Labs has announced a new FDA-approved, drug-free hemorrhoid treatment device that is expected to revolutionize the hemorrhoid treatment market. Produced by Hemor*Rite, a Med-Rite Labs Company, this pain relief therapy is delivered by an FDA designated, Class II medical device, using Cryotherapy (cold therapy), that effectively reduces the internal and external swelling of the hemorrhoidal tissue.
Hemor*RiteTM Cryotherapy is an anatomically designed device for applying cold therapy (Cryotherapy) directly to the swollen hemorrhoidal veins of the external hemorrhoids and the internal hemorrhoids within the rectal cavity. The Cryotherapy device can be used for 8 minutes and delivers up to 10 hours of hemorrhoid relief, making it the most effective non-surgical treatment available on the market for the treatment of hemorrhoids.
Hemorrhoids cannot be cured but they can be controlled. Over 125 million people in the U.S. suffer from hemorrhoids, in addition to a major percentage of the global population. This condition is growing at an ever-increasing rate due to diets, pregnancy, lifestyle, and other reasons which exacerbate the condition. Hemor*Rite Cryotherapy enters the market at a time when the global population needs an effective treatment for hemorrhoids to resume regular daily activities.
"Med-Rite Labs' research and development has resulted in the most effective and innovative treatment available in the market for hemorrhoid relief. As a result, millions of people will benefit from this medical breakthrough," states Frank Melendez, Vice President of Research and Development for Med-Rite labs.
Med-Rite Labs and Hemor-Rite Cryotherapy will be exhibiting at the MEDICA Trade Show in Düsseldorf, Germany on November 16-19th. Visitors can find the booth at Hall 7-B33.
About Med-Rite Laboratories
Med-Rite Laboratories, a Dallas-based medical device and over the counter drug company, was formed to acquire and commercialize proprietary health care technologies for professional and retail distribution. The Company is vertically integrated with total internal capabilities including; product development, product testing, global government certifications (e.g., FDA, CE, etc.), patent protection, manufacturing, domestic and international distribution, state of the art customer-call center support, Ecommerce, and complete domestic and international logistics capabilities as well as media and print advertising support.
For more information, please go to www.medritelabs.com or contact Larry Ferk, VP Of Global Sales email@example.com